32 results
8-K/A
EX-99.1
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
a pandemic. As of the date of the consolidated financial statements were issued, Elicio’s operations have not been significantly impacted by the COVID-19 … , the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted in response to the COVID-19 pandemic. The CARES Act, among other
8-K/A
EX-99.2
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
disease 2019 (COVID-19) outbreak a pandemic. As of the date of the consolidated financial statements were issued, Elicio’s operations have not been
8-K
EX-99.5
ELTX
Elicio Therapeutics Inc.
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
will need to delay, reduce or terminate planned activities to reduce costs.
The COVID-19 pandemic continues to evolve. While it appears its most … severe effects have subsided, COVID-19 could re-emerge or new public health threats could appear. The future impact of the COVID-19 pandemic or a similar
8-K
EX-99.4
gfzax6b01l g5ca
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
eiyzvo wtw
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
nvekch9gfg
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
S-4/A
EX-10.34
uzzwykc391z162k456k2
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
424B5
kbfrlqr3uyza969
24 May 22
Prospectus supplement for primary offering
4:02pm
424B3
wkk8v9
24 May 22
Prospectus supplement
4:01pm
S-3
mzvi36564sgxh 9x86s3
16 May 22
Shelf registration
5:23pm
DEF 14A
dctqxpqm
27 Apr 22
Definitive proxy
4:04pm